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Introduction
Nitric oxide (NO) is a ubiquitous signaling molecule with multiple systemic and airway roles.
Cystic fibrosis (CF) is a chronic lung condition which is associated with decreased fraction of exhaled NO (FeNO) [1] [2] [3] [4] .
The impact of decreased FeNO in CF is unclear. However, potentially of relevance to CF, NO has bronchoprotective, anti-inflammatory and anti-infective roles as well as effects on ion transport 5 and ciliary motility 6 . Interestingly, pulmonary function in CF subjects is positively correlated to airway NO 7 and sputum NO metabolites 8 . Further, NO deficiency contributes to impairment of airway relaxation in a murine model of CF 1 . Therefore, increasing NO levels may be of functional importance in CF. Strategies to increase FeNO in CF have included inhaled NO, L-arginine and PDE5 inhibitors (e.g. sildenafil ®) but have yielded inconsistent safety and efficacy profiles (table 3) .
Until recently, it was thought that the only pathway for NO synthesis in vivo was via oxidation of L-arginine in the presence of oxygen catalysed by NO synthase (NOS) enzymes. However recently an alternative pathway for in vivo NO synthesis has been discovered whereby inorganic nitrate is reduced by oral bacteria to nitrite. This nitrite can be further reduced to NO enzymatically and non-enzymatically 9 
Case report
We present a 12 year-old, non-smoking, athletic, male (BMI = 19 kg/m 2 ) with CF, normal lung function (FEV 1 = 105%) and pancreatic sufficiency. This case initially presented early in life with a history of recurrent chest infections and wheezy episodes. An initial sweat test chloride of 112 and confirmatory sweat test chloride of 106 in addition to genotype analysis (F508/c.262_263delTT) lead to a CF diagnosis at 9 months of age. Current investigations revealed a normal x-ray, DEXA, and glucose tolerance test with no recent hospital admissions or gastrointestinal symptoms. Further, the case had no other medical history of note, including no asthma or allergy (which could influence FeNO measurement). He generally requires antibiotics every 8-12 weeks but had no recent infection or antibiotic use and had no evidence of concurrent bacterial colonization. Further his medication regimen was stable and typical for a CF case (table   1) . We utilized a double-blind, randomized, placebo-controlled, crossover design to assess the acute impact of dietary nitrate as 140ml beetroot juice (BRJ, 12.9mmol nitrate) or 140ml matched, nitrate-depleted beetroot juice (PL, <0.5mmol) on exhaled NO. This nitrate dose is obtainable with a diet rich in vegetables.
We conducted two clinic visits 14 days apart, where there were no relevant changes in factors known to influence NO (including diet, exercise and medication habits). On the morning of each study visit, the subject did not use any medications or complete chest physio and consumed an identical, low nitrate breakfast which was confirmed by a review with a dietitian (CPK). On both Dietary nitrate increases exhaled nitric oxide Page 5 Copyright ©2016 Marshfield Clinic Health System days, in an identical manner and at the same time, FeNO (NiOx MINO; Aerocrine, Sweden) and pulmonary function were assessed before and 1.5h after the study beverage. We added water and blackcurrant cordial (sugar-and nitrate-free) to the juice in an identical manner on both days to make it more palatable at the request of the subject. The 1.5h delay between baseline and postbeverage testing was to facilitate in-vivo reduction of dietary nitrate to NO 9 . During this delay, the case rested quietly in a clinic room and did not exercise, eat, drink or take medication. This case report intervention complies with the Declaration of Helsinki and approval was granted by the research ethics committee of The National Children's Hospital. Written informed consent was provided by the mother for permission to conduct and publish this case report.
There was no effect on pulmonary function after either beverage. However, 1.5h following BRJ, FeNO increased by 150% (30ppb) but decreased by 17% after PL (-4ppb) ( figure 1 and table 2 ).
Discussion
To our knowledge, this is the first report of dietary nitrate in CF. The acute but marked FeNO incease following dietary nitrate compares favourably to other NO therapies in CF (table 3) .
Interestingly, the subject studied here did not have low baseline FeNO (20ppb). Dietary nitrate as a precursor to NO seems most effective in those with dysregulated NO and therefore it is possible that dietary nitrate may increase FeNO to a similar or greater extent in those with diminished baseline FeNO. Despite an increase in FeNO, there was no effect on lung functon. In this context, it is noteworthy that baseline lung function was not impaired (105%), perhaps minimising any potential benefit.
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Dietary nitrate is water soluble and rapidly absorbed ~100% in the stomach and small intestine.
There is no evidence of nitrate malabsorption in CF. Approximately 75% of ingested nitrate is excreted via the kidneys with the remainder concentrated in the oral gland and subsequently reduced to nitrite by tongue anaerobes. This nitrite is swallowed and then further reduced to NO under suitable conditions within the airway, stomach and endothelium. After nitrate ingestion, salivary/plasma nitrate levels increase rapidly (~15m) and peaking at 90-120m 13 . The levels remain high for several hours following ingestion after which they slowly decline, remaining elevated from baseline for ~24h 13 . This is why we measured FeNO before and 1.5h after each of 2 beverages. Further, we measured total exhaled NO. Future studies may utilize different doses of nitrate among larger groups as well employ serial measurements of NO, nitrate and nitrite to further our understanding of NO metabolism in response to exogenous nitrate in CF.
Importantly, this CF case did not display several behaviors known to decrease the reduction of dietary nitrate to NO including use of tobacco 14 antibiotics 15 or mouthwash 16 .
Although, our report is limited to a single male, CF case with mild disease, dietary nitrate is a component of certain vegetables, appears remarkably safe and increased FeNO to a greater extent than exisitng CF therapies.
Nitrate and nitrate, as precursors to NO, are known to have broad antimicrobial effects 10-12 , including against common pathogens in CF such as Pseudomonas aeruginosa 10 
